Group News
-
The Earth Day：Fosun Actively Promotes “Dual Carbon Goals”
2024.05.03
-
Fosun Enhances Global Operations Through “Deep Mining” to Focus on Core Businesses, Creating Happier Lives for Families Worldwide
2024.04.25
-
Fosun international Reports Revenue and Profit Growth in 2023 Chen Qiyu: Focus on “Deep Mining” for a Promising Future
2024.04.25
-
2024.04.25
-
Fosun Tourism Receives Higher Ratings and Scores for ESG Performance from International Rating Agencies - The Only MSCI AAA-rated Company in Hotel and Travel Industry in Greater China Region
2023.03.14
-
2023.03.14
-
S&P releases Fosun International’s ESG score report: Fosun International’s ESG score improves significantly.
2022.10.06
-
2022.09.26
-
Fosun Establishes Major Technological Innovation Projects in Pudong, Shanghai
2022.09.26
-
Fosun Group Visited Beijing SASAC, Conducted discussion on relevant cooperation
2022.09.26
-
Fosun Holds Its 4th “515 Fosun Family Day” as Scheduled
2022.05.16
-
Fosun Foundation’s 40-day Anti-epidemic Efforts to Protect Shanghai Do More and Do Better for the City
2022.05.12
-
Henlius and Eurofarma Entered into a License Agreement for Henlius' 3 Products in Latin America
2022.05.11
-
Fosun International 2021 ESG Report Highlights in a Glance
2022.04.29
-
World Malaria Day | Fosun Pharma’s Self-Developed Artemisinin Series Become Symbol of China’s Innovative Medicines
2022.04.25
-
Paving the Last Mile, Fosun Foundation Delivers Essentials to Hundreds of Communities in Shanghai
2022.04.19
-
Fosun Diagnostics Receives China NMPA Approval for Its Independently Developed Novel Coronavirus Antigen Detection Kit amidst of the National Efforts in Pandemic Prevention and Control
2022.04.13
-
Chen Qiyu, Co-CEO of Fosun International: During the Two Years of the Epidemic, Fosun Deepens Industry Operations + Investment to Build “Internal Capabilities”
2022.04.07
-
Xu Xiaoliang, Co-CEO of Fosun International: Planning the Post-Pandemic Era
2022.04.01
-
Fosun Foundation’s Second Batch of More Than 500,000 Pieces of Anti-epidemic Materials Arrives in Hong Kong Successively to Aid High-risk Groups and Grassroots Families
2022.03.10
-
Targeted Anti-Epidemic Support, Fosun Foundation Delivers the First Batch of Anti-epidemic Materials to Grassroots Families in Hong Kong
2022.03.02
-
汉利康Ⓡ Approved by NMPA for New Indication Differentiated Strategy Benefits a Wider Patient Population
2022.03.01
-
Fosun Foundation’s First Batch of 250,000 Sets of COVID-19 Rapid Antigen Test Kits Arrives in Hong Kong
2022.02.25
-
Henlius Entered into a Collaboration with Getz Pharma to Commercialise Adalimumab Biosimilar 汉达远, Covering 11 Emerging Markets in Asia, Africa and Europe
2022.02.23
-
Fosun Foundation Donates First Batch of HK $10 Million Anti-epidemic Materials to Hong Kong
2022.02.19
-
Fosun Establishes Consumer Technology Fund, Building Shanghai into a “City of Design”
2022.02.18
-
Fosun Tourism delivered outstanding performance during the Chinese New Year Holiday, High-quality products lead new trends in ice, snow and island vacations
2022.02.09
-
Fosun to Build a “Coastal City Parlor” in the Shanghai Bay Area
2022.02.07
-
Xu Xiaoliang: Fosun’s Species, Fosun’s Ecosystem, Fosun’s Future
2022.01.20
-
Chen Qiyu: Consolidating Organizational Capabilities, Achieving New Growth Towards a Brighter Life
2022.01.19
-
Wang Qunbin: High Multiplier Value Growth, Building a Better World
2022.01.18
-
Guo Guangchang: Keep Calm and Trust Fosun
2022.01.17
-
Fosun's Intelligent Manufacturing: China's First Privately-owned High-speed Railway Starts Operation
2022.01.10
-
Fosun International’s MSCI ESG rating upgraded to AA
2022.01.06
-
Guo Guangchang New Year’s Sharing: Believe in the Power of Perseverance
2022.01.01
-
Fosun International Garners the “Gold Award” at The Asset ESG Corporate Awards 2021
2021.12.17
-
Fosun Diagnostics Launches New COVID-19 test kit for Omicron Variant!
2021.12.16
-
Confirming the financial robustness of the Company, Fitch rates Fidelidade at A
2021.12.15
-
Fosun Pharma Participates in the BEYOND Expo Presents innovation-driven ecological layout of the healthcare industry
2021.12.03
-
Hangzhou-Shaoxing-Taizhou Railway, the first high-speed railway majority-owned by private investors in China, put on trial run
2021.11.29
-
Fosun Participates in the Inaugural Asia Summit on Global Health, Actively Promoting Collaborations in Global Health
2021.11.25
-
Lanvin Group Unveils New Brand Identity
2021.11.23
-
Nature: Making Biologic Medicines More Accessible
2021.11.22
-
Oriental Aesthetics Brings Out the Beauty of Life: the 10th Shanghai Haute Couture Week Successfully Concludes
2021.11.19
-
Rural Doctors go on an “Immersive” Tour at the CIIE: “Two Days Felt Like Two Months”
2021.11.07
-
Oriental Haute Couture, Ultimate Aesthetics - Shanghai Haute Couture Week to Open in November
2021.10.21
-
Fosun Sports Group Announces New Entity to Deepen Global Sports Industry Footprint
2021.10.19
-
International Biopharma Industry Week Shanghai Opens, Fosun Helps to Promote the High-quality Development of Shanghai’s Biopharma Industry
2021.10.14
-
Fosun's German private banking unit H&A acquires full ownership of Bankhaus Lampe
2021.10.09
-
2021 Fosun Family Season to Set the “Fosun China-Chic” and Launch Fosun Membership System “Fosun Alliance”
2021.10.04
-
2021 Fosun Family Season to Set the “Fosun China-Chic” and Launch Fosun Membership System “Fosun Alliance”
2021.09.30
-
FOLIDAY’s New Quality Lifestyle under Snowy Mountains, Club Med Lijiang Opens
2021.09.29
-
Fosun Attends Shanghai Tourism Investment Promotion Conference, Building Shanghai into a World-renowned Premium Tourist City
2021.09.26
-
Guo Guangchang, Chairman of Fosun International and Bill Winters, CEO of Standard Chartered PLC Hold a Video Conference
2021.09.24
-
Hauck & Aufhäuser Acquires Kapilendo Custodian AG as One of the First Crypto Custodians with Permission to Custody Crypto Asset
2021.09.16
-
Promoting Rural Health and Common Prosperity, Fosun’s Rural Doctors Program Receives “China Charity Award”
2021.09.06
-
Guo Guangchang and Management Team had In-depth Exchange with Investors and Media on Fosun International 2021 Interim Results
2021.08.27
-
Fosun Tourism Announces 2021 Interim Results Global Travel Restarted and Continues to Improve Financial Position Remains Healthy Long Term Growth with a Bright Future
2021.08.19
-
Fosun International Granted Three Awards from Global Banking and Finance Review in the United Kingdom
2021.08.06
-
Fosun Foundation Officially Kicks off "New Mihe Project",First Batch of Medical Supplies Delivered to Mihe Health Cente
2021.08.01
-
Fosun Foundation donates RMB50 million disaster relief to Henan
2021.07.21
-
Thomas Cook Celebrated 180th Anniversary with New International App
2021.07.19
-
The first high-speed railway majority-owned by private investors in China completed
2021.06.29
-
China's first CAR-T Cell Therapy approved-Fosun Kite Axicabtagene Ciloleucel (FKC876)
2021.06.25
-
Fosun Fashion Group to Acquire Italian Luxury Shoemaker Sergio Rossi
2021.06.16
-
Oxygen Concentrators have arrived! 135 oxygen concentrators donated by Fosun and its friendly enterprises arrive in Mumbai
2021.06.01
-
Guo Guangchang and Liu Jin, President of Bank of China held a meeting to promote win-win cooperation between the bank and the enterprise
2021.05.18
-
What is a “Happy Planet”? Starting today, let’s take a closer look at the China International Consumer Products Expo with Fosun!
2021.05.13
-
Fosun and Baoding Med-Joy Medical team up to aid India with 15,000 oxygen concentrators to provide oxygen to local patients
2021.05.03
-
Swift support for India - Fosun's more aid of 100,000 KN95 masks arrived in Mumbai
2021.05.01
-
World Malaria Day | Fosun joins in the global fight for a malaria-free world
2021.04.27
-
Fosun International Announces 2020 Annual Results: Total Revenue Amounted to RMB136.6 Billion, Gathering Strength to Fuel Growth
2021.03.30
-
BioNTech and Fosun Pharma Jointly Announce the Arrival of the First Batch of COVID-19 mRNA Vaccine in Hong Kong and Macau
2021.02.27
-
MOODY’S ASSIGNS FIRST-TIME A3 IFSR TO FIDELIDADE MACAU
2021.01.22
-
Henlius Daratumumab Biosimilar Received IND Approval from NMPA
2021.01.13
-
NMPA Has Accepted The NDA of HLX01 (Rituximab Injection) for the Treatment of Rheumatoid Arthritis
2020.12.17
-
Henlius Adalimumab Biosimilar 汉达远® Approved by NMPA
2020.12.07
-
Investigational New Drug Application of Henlius SARS-CoV-2 Neutralizing Antibody HLX70 Approved by US FDA
2020.10.05
-
Fosun successfully held FC2M Conference to expedite further industry operations development
2020.09.09
-
Fosun International’s HSI ESG rating upgraded, Selected as constituent of Hang Seng Corporate Sustainability Benchmark Index
2020.09.07
-
Fosun International Announces 2020 Interim Results Total revenue reaches RMB63.27 billion, demonstrating a rapid business recovery
2020.08.27
-
Challenge Dilemmas in The Treatment of SCCHN, Henlius Innovative Combination Therapy Dosed The First Patient in A Phase 2 Clinical Trial
2020.07.30
-
Fosun Pharma Announces its Licensed COVID-19 Vaccine Product Receives Acceptance Notice of Clinical Trial Application by NMPA
2020.07.14
-
Fosun kicked off “Thousand Talents Program” and recruited 1,000+ fresh graduates with Guo Guangchang’s engagement
2020.06.30
-
Helps the World Fight Coronavirus with Global Resources
2020.03.01
-
I Finally Understand What Wartime Supplies Mean; 330K Masks And 270K Protective Medical Suits Are Coming
2020.01.29
-
First Batch of Fosun’s Donated Medical Supplies Arrives in Shanghai Amid Global Procurement
2020.01.28
-
1970.01.01
